Transcatheter aortic valve replacement (TAVR) was associated with lower in-hospital mortality and significantly fewer respiratory complications than surgery for patients with chronic obstructive pulmonary disease (COPD), according to study published April 1 in the Journal of the American Heart Association.

According to a new study in JAMA, people who lost at least 75 percent of their net worth in a two-year period showed a 50 percent increased risk of dying over two decades compared to those who maintained positive wealth.

Chicago-based Outcome Health announced a collaboration with advocacy group WomenHeart: The National Coalition for Women with Heart Disease, to “provide actionable educational information” to cardiology providers across Outcome Health’s network of providers.

Outcomes-based pricing agreements would do little to help the poor cost-effectiveness of PCSK9 inhibitors. The event rates in preventive medicine are simply too low and medication costs too high for such a compromise to make a difference, a group from University of California, San Francisco reported in the Annals of Internal Medicine.

GE Healthcare has announced it will sell its revenue cycle, ambulatory care and workforce management software units to private equity firm Veritas Capital for $1.05 billion, following earlier plans for General Electric to sell assets and rumors the entire company could be broken up.

Individuals who consume large amounts of meat protein experience a 60 percent increase in cardiovascular disease (CVD), according to research published in the International Journal of Epidemiology on April 3.

Already approved for the purpose its name implies, the Gore Cardioform septal occluder has also received the FDA’s OK for patent foramen ovale (PFO) closure to prevent recurrent ischemic stroke.

Heart failure was not associated with an increased risk of cancer in a study of almost 30,000 men despite previous reports linking the two conditions.

The number of patients admitted to U.S. hospitals for infective endocarditis (IE) related to IV drug use has more than doubled over the last several years, racking up an average of $72,000 in expenses each time.

Atrial fibrillation (AFib) ablation techniques used on individuals without cardiac abnormalities can be safely applied to adults with congenital heart disease (CHD), according to a new study in JACC: Clinical Electrophysiology. But in many cases, multiple ablation procedures are needed to boost the chances of arrhythmia-free survival.

Women whose babies are born with congenital heart defects may have a higher risk of cardiovascular disease themselves, according to a study of more than one million women published online April 2 in Circulation.